What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
The scientist’s investigation covers issues in Lung cancer, Carcinoma, Survival rate, Adenocarcinoma and Surgery.
His Lung cancer research includes themes of Stage, Metastasis and Lung.
His work in Carcinoma addresses subjects such as Lymph node, which are connected to disciplines such as Radiology, Small-cell carcinoma and Lymphatic system.
Hisao Asamura interconnects Survival analysis and Dissection in the investigation of issues within Survival rate.
Hisao Asamura has researched Surgery in several fields, including Lung cancer surgery, Mediastinal lymph node and Pneumonectomy.
His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His most cited work include:
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. (1326 citations)
- The IASLC lung cancer staging project: A proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer (708 citations)
What are the main themes of his work throughout his whole career to date?
Hisao Asamura spends much of his time researching Lung cancer, Internal medicine, Pathology, Lung and Surgery.
His work carried out in the field of Lung cancer brings together such families of science as Survival rate, Carcinoma, Radiology, Stage and Adenocarcinoma.
His work in Adenocarcinoma addresses issues such as Cancer research, which are connected to fields such as Epidermal growth factor receptor.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His Oncology study incorporates themes from Adjuvant chemotherapy and Clinical trial.
His primary area of study in Lung is in the field of Respiratory disease.
He most often published in these fields:
- Lung cancer (48.50%)
- Internal medicine (30.75%)
- Pathology (27.75%)
What were the highlights of his more recent work (between 2015-2021)?
- Lung cancer (48.50%)
- Internal medicine (30.75%)
- Oncology (23.50%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Lung cancer, Internal medicine, Oncology, Lung and Pathology.
His studies in Lung cancer integrate themes in fields like Surgery, Cancer and Radiology.
His work on Stage, Hazard ratio and Tegafur is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
The Oncology study combines topics in areas such as Adjuvant chemotherapy, Epidermal growth factor receptor, Metastasis and MEDLINE.
Hisao Asamura usually deals with Lung and limits it to topics linked to Adenocarcinoma and Pathological, Survival rate, Immune system, Poor prognosis and Tumor size.
The concepts of his Pathology study are interwoven with issues in Resection and General surgery.
Between 2015 and 2021, his most popular works were:
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. (1326 citations)
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (260 citations)
- Scientific Advances in Lung Cancer 2015 (138 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Hisao Asamura mainly investigates Lung cancer, Internal medicine, Oncology, Adenocarcinoma and Lung cancer staging.
His studies deal with areas such as Cancer, Metastasis, Radiology, Lung and Stage as well as Lung cancer.
His research investigates the connection with Lung and areas like Pathology which intersect with concerns in Second primary cancer, Basal and Neutrophil to lymphocyte ratio.
His research integrates issues of Pathological, Radiation therapy, Perioperative, Surgery and Thymic carcinoma in his study of Oncology.
The various areas that Hisao Asamura examines in his Adenocarcinoma study include Survival rate, Nodule, Immune system, 18F-Fluoroazomycin Arabinoside and Chemoradiotherapy.
His Lung cancer staging study integrates concerns from other disciplines, such as Background data and Biostatistics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
